Curcumin improves the therapeutic efficacy of Listeriaat-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Curcumin improves the therapeutic efficacy of Listeriaat-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1
Authors
Keywords
-
Journal
Cancer Medicine
Volume 2, Issue 4, Pages 571-582
Publisher
Wiley
Online
2013-07-02
DOI
10.1002/cam4.94
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers
- (2012) Xin-Sheng Deng et al. CELL CYCLE
- Dietary supplementation with curcumin enhances metastatic growth of Lewis lung carcinoma in mice
- (2012) Lin Yan INTERNATIONAL JOURNAL OF CANCER
- Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL
- (2011) P. Sinha et al. BLOOD
- Curcumin Induces the Differentiation of Myeloid-Derived Suppressor Cells and Inhibits Their Interaction with Cancer Cells and Related Tumor Growth
- (2011) S. P. Tu et al. Cancer Prevention Research
- CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome
- (2011) Michael O. Idowu et al. HUMAN PATHOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways
- (2011) Hong Zong et al. MOLECULAR BIOLOGY REPORTS
- Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma
- (2011) Reason Wilken et al. Molecular Cancer
- Cancer-testis antigen expression in triple-negative breast cancer
- (2010) G. Curigliano et al. ANNALS OF ONCOLOGY
- Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer
- (2010) Carlos H. Barrios et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeted Therapy in Breast Cancer: Current Status and Future Directions
- (2010) H. Mukai JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Breast Cancer Stem Cells
- (2010) Suling Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Tranilast inhibits the growth and metastasis of mammary carcinoma
- (2009) Rabindranath Chakrabarti et al. ANTI-CANCER DRUGS
- Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast cancer
- (2009) F Castro et al. BRITISH JOURNAL OF CANCER
- High Efficacy of a Listeria-Based Vaccine against Metastatic Breast Cancer Reveals a Dual Mode of Action
- (2009) S. H. Kim et al. CANCER RESEARCH
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- The Increasing Complexity of the Cancer Stem Cell Paradigm
- (2009) J. M. Rosen et al. SCIENCE
- Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases
- (2008) S H Kim et al. BRITISH JOURNAL OF CANCER
- Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2008) Nancy U. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now